Ujjeewan Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.75 M
as on 14-12-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.96 M
as on 14-12-2024
- Revenue -13.44%
(FY 2020)
- Profit -58.63%
(FY 2020)
- Ebitda -19.40%
(FY 2020)
- Net Worth 12.78%
(FY 2020)
- Total Assets 8.74%
(FY 2020)
About Ujjeewan Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹0.96 M.
Mahesh Saraf and Manish Saraf serve as directors at the Company.
- CIN/LLPIN
U85110WB2010PTC140729
- Company No.
140729
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ujjeewan Healthcare Private Limited offer?
Ujjeewan Healthcare Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Medical Consultancy Services, Web Development & Marketing Services, Website Development Services, Insurance Service, Health Insurance.
Who are the key members and board of directors at Ujjeewan Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Saraf  | Director | 06-Jan-2010 | Current |
| Manish Saraf | Director | 06-Jan-2010 | Current |
Financial Performance of Ujjeewan Healthcare.
Ujjeewan Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.44% decrease. The company also saw a substantial fall in profitability, with a 58.63% decrease in profit. The company's net worth Soared by an impressive increase of 12.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ujjeewan Healthcare?
In 2020, Ujjeewan Healthcare had a promoter holding of 99.33% and a public holding of 0.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Oct 2020 | ₹0.16 M | Open |
Others Creation Date: 05 Mar 2014 | ₹0.80 M | Open |
How Many Employees Work at Ujjeewan Healthcare?
Unlock and access historical data on people associated with Ujjeewan Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ujjeewan Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ujjeewan Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
